We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Device Speeds Sample Preparation

By Biotechdaily staff writers
Posted on 02 Sep 2005
A new dielectrophoretic device may revolutionize sample preparation by delivering detectable amounts of material in small water sample volumes, eliminating any need for overnight culturing and speeding up overall water analysis.

The insulator-based dielectrophoretic device (iDEP) concentrates live pathogenic bacteria within large water samples. More...
In addition to water analysis, the technology may also have applications beneficial to a host of other applications. The technology was developed by researchers at Sandia [U.S.] National Laboratories (Livermore, CA, USA).

The scientists at Scandia are developing application-specific iDEP devices and architectures for concentrating and separating bacteria, spores, viruses, and other particles. iDEP could also enable verification of biologic decontamination efficacy for viable cell populations, as contrasted to inactivated cells and denatured proteins. For public health purposes, it could improve water analysis and spore and vegetative cell differentiation. In addition, iDEP could separate nanoparticles and nanotubes for materials synthesis.

Scandia is seeking commercial partners to further develop the technology to differentiate between live and dead cells for cell culturing; to sort anomalous cells to diagnose diseases such as cancer, sickle cell anemia, and leukemia; and to concentrate and focus on samples for proteomics research and drug discovery.

"In laboratories, iDEP could contribute to differential sorting of live and dead cells in cell culturing, and allow for protein isolation and concentration, sample concentration and focusing, analytical chemistry, and mass spectrometry for proteomics and drug discovery,” observed Carrie Burchard, a business development manager at Sandia.




Related Links:
Sandia Nat'l Laboratories

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Multi-Chamber Washer-Disinfector
WD 390
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.